Velpanat is a fixed-dose combination medication for the treatment of hepatitis C in adults. It combines sofosbuvir and velpatasvir.
It is more than 90% effective for hepatitis C genotypes one through six.
It also works for hepatitis C in those who also have cirrhosis or HIV/AIDS.
Velpanat is a single tablet regimen is used for adults with genotype 1–6 chronic hepatitis C virus (HCV) infection.
